Status:
COMPLETED
PK Analysis of Piperacillin in Septic Shock Patients
Lead Sponsor:
University of Aarhus
Conditions:
Septic Shock
Eligibility:
All Genders
18+ years
Brief Summary
Antibiotic dosing in septic shock patients poses a challenge for clinicians due to the pharmacokinetic changes seen in this population. Piperacillin/tazobactam is often used for empirical treatment, a...
Detailed Description
Early appropriate antimicrobial therapy is of utmost importance for reducing mortality in critically ill patients with sepsis and septic shock. Patophysiological changes associated with the septic pro...
Eligibility Criteria
Inclusion
- Treatment with piperacillin/tazobactam for less than 24 hours. Treatment with noradrenaline. -
Exclusion
- Renal replacement therapy. Age under 18.
- \-
Key Trial Info
Start Date :
September 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2015
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT02306928
Start Date
September 1 2014
End Date
January 1 2015
Last Update
February 11 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of anesthesiology and intensive care, Aarhus University Hospital
Aarhus N, Denmark, 8200